Sequencing in China is on a rapid rise, with the country accounting for 20%–30% of global sequencing capacity. Driving this growth is China’s 15-year precision medicine program (see IBO 1/31/16). The multi-billion dollar budget of the initiative will be used for improving precision medicine technology, sequencing, analyzing over a million human genomes, and drug development […]
In 1999, R&D made up 2.07% of South Korea’s GDP and by 2014, that number reached 4.29%, or $60.5 billion. This makes South Korea the global leader in R&D investment as a percentage of GDP, followed by Israel, Japan, the US, China and the EU. By 2017, the country plans to increase R&D investment to […]
In a survey of 400 respondents examining corporate R&D spending in 10 Central European countries (Croatia, Czech Republic, Estonia, Hungary, Lithuania, Latvia, Poland, Romania, Slovakia, Slovenia), 45% of companies plan to increase R&D spending in the next 1–2 years, and 57% plan to increase it in the next 3–5 years. Respondents in Slovakia, Croatia and […]
Globally, IPOs in the biotechnology industry have slowed in the first quarter; however, biotech venture capital (VC) in the UK has remained strong since 2015, accounting for 27%, or £178 million ($201.8 million), of the EU’s total biotech VC financing. In 2015, £489 million was raised in VC, a 51.4% increase. The 2015 trend of […]
French President François Hollande has announced the cancellation of over half of the government’s proposed budget cuts to scientific research. Originally, the government was planning to make reductions totaling €256 million ($200 million) in the research and higher education sectors. In May, many leaders in the scientific community protested that the budget cuts would adversely […]
Last month, the UK announced the formation of the United Kingdom Research and Innovation (UKRI) funding organization. The body is made up of the country’s seven Research Councils, Innovate UK and the Higher Education Funding Council for England (HEFCE), and will work autonomously from the government in allocating funding for research and innovation. UKRI is […]
Following the impeachment of Brazilian President Dilma Rousseff last month, interim President Michel Temer combined the country’s Ministry of Science, Technology and Innovation (MCTI) with the telecommunications and internet regulations ministry. Brazilian scientists have been protesting the integration, which they believe will greatly debilitate scientific R&D. Since 2013, authorized funding for the MCTI has been […]
By 2020, the Chinese pharmaceutical market is projected to be valued at $120 billion, although the lack of R&D in the industry is currently holding back further growth and innovation. This is due largely in part to slow regulatory and review processes that can delay drug approvals for up to eight years. The China Food […]
As part of Beijing’s $40 billion Silk Road Fund, created for the implementation of Beijing’s “One Belt, One Road” policy aiming to improve economic cooperation and markets between China and the rest of Eurasia, China has announced plans to invest $1.9 billion in Kazakhstan’s agriculture industry. Although Kazakhstan is eighth among the top 10 wheat […]
Due to low oil and gas prices in Canada, planned government and company expenditures on corporate construction, and machinery and equipment is projected to decrease 4.4% this year to CAD $241.6 billion ($186.6 billion). So far, capital expenditures for 2016 in the private sector have decreased 9.3%, hitting CAD $157.4 billion, while public companies’ expenditures […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
